VTRS News

Latest breaking news and updates for VTRS stock.

Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.

Approval is Another Milestone of Viatris' Ability to Successfully Develop Complex Generic Medicines Approval Granted with Competitive Generic Therapy Eligibility for 100mg/5mL and 200mg/10mL Streng...

What are the long‑term implications for Viatris’ pipeline of complex generic medicines and future market opportunities? What regulatory or litigation risks could arise from this product’s launch? How will the new product affect Viatris' cash flow and dividend policy in the short‑term?

Regulation

17 days ago

Viatris Reports Second Quarter 2025 Results and Reiterates 2025 Financial Guidance

Delivers Total Revenues Above Expectations Reflecting the Strength of our Execution and the Resilience of our Diversified Global Business Positive Results From Five Phase 3 Data Readouts This Year ...

How could the positive momentum from the late‑stage pipeline affect VTRS's dividend policy or share repurchase plans? Will the strong Q2 results lead to a change in analyst consensus or earnings forecasts for VTRS? What is the expected impact of the Phase 3 results on the company's long‑term pipeline valuation and potential M&A activity?

Earnings

21 days ago